Athira Pharma gets new finance chief
- Clinical-stage biopharmaceutical company, Athira Pharma (ATHA) appoints Andrew Gengos as CFO and Chief Business Officer, effective immediately.
- Mr. Gengos replaces Glenna Mileson, who is retiring after serving as Athira’s CFO for eight years.
- Mr. Gengos is a seasoned finance and corporate strategy executive and most recently, he served as the chief business officer at Cyteir Therapeutics.